Serge Belanger
Stock Analyst at Needham
(1.97)
# 1060
Out of 5,297 analysts
374
Total ratings
46.89%
Success rate
13.38%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeut... | Reiterates: Buy | 20 20 | 16.64 | 20.19% | 19 | Apr 3, 2025 | |
OMER Omeros | Reiterates: Hold | n/a | n/a | n/a | 6 | Apr 1, 2025 | |
CLSD Clearside Biomedical | Maintains: Buy | 6 4 | 0.93 | 330.11% | 13 | Mar 28, 2025 | |
KALV KalVista Pharma | Reiterates: Buy | 28 28 | 11.11 | 152.03% | 19 | Mar 26, 2025 | |
CRMD Cormedix | Maintains: Buy | 18 12 | 6.33 | 89.57% | 15 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 19 25 | 14.5 | 72.41% | 27 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 24 | 6.3 | 280.95% | 19 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 17 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 7.29 | 105.76% | 1 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 22 22 | 12.29 | 79.01% | 13 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 32 | 24.86 | 28.72% | 26 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 2.24 | 78.57% | 21 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 46 42 | 18.34 | 129.01% | 6 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 62 66 | 38.06 | 73.41% | 11 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 72 72 | 40.36 | 78.39% | 20 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 21 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 14 15 | 7.42 | 102.16% | 11 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 46 | 29.97 | 53.49% | 24 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 38 | 13.1 | 190.08% | 15 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 6 6 | 1.4 | 328.57% | 17 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 31.45 | 90.78% | 11 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 4 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 8 | Aug 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Aug 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Mar 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 5 | Jan 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | n/a | n/a | 3 | Aug 5, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Feb 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jul 1, 2020 |